Windtree Therapeutics sells Seismic IP and related assets to Seismic Operations for USD 150,000
Reuters2026/07/22 10:02- Windtree Therapeutics agreed to sell Seismic Pharmaceuticals’ cardiovascular program assets to Seismic Pharmaceuticals Operations in an asset purchase agreement dated Dec. 16, 2025.
- Upfront consideration totals USD 150,000 cash at closing.
- Windtree can receive USD 700,000 if the buyer completes a post-closing financing of at least USD 10 million.
- Windtree is also entitled to 20% of certain license-out economics tied to the transferred intellectual property, with a USD 1.2 million buyout option following a qualifying financing.
- The deal includes a planned transfer of control of a Taiwanese subsidiary effective no earlier than Jan. 1, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Dogecoin’s rare setup mirrors 2022 – Can DOGE repeat its 140% rally?
Bitcoin falls 47%, Strategy’s STRC preferred stock returns 9% in one year
Spot DEXs on Solana see $5.8B in trading volume for tokenized stocks
Turmoil Intensifies Within OpenAI: Ongoing Restructuring, Employee Exhaustion, Continued Management Resignations, IPO Plans Quietly Delayed
OpenAI has undergone nearly five restructurings this year, with a continued wave of executive departures. Chief Revenue Officer Denise Dresser became the latest to leave this week. The company also disbanded its safety team responsible for assessing the "catastrophic risks" of AI models, raising internal concerns. Although revenue has increased to about $40 billion, OpenAI has been surpassed by Anthropic. Employees generally feel exhausted, and the IPO plans have quietly been postponed until next year.
Crypto prices
More
